No. of Pages: 136 | Report Code: BMIRE00028339 | Category: Life Sciences
2022年北美肺功能测试系统市场价值为1.0842亿美元，预计到2028年将达到1.6073亿美元；据估计，2022 年至 2028 年复合年增长率为 6.8%。
肺部相关疾病发病率上升推动北美肺功能测试系统的发展市场
PFT 系统提供准确的结果，特别是肺容量、容量、流速和气体交换。 PFT 系统的利用有助于评估哮喘、肺气肿和其他慢性肺部问题的治疗。通过评估肺容量、容量、流速和气体交换，PFT 可以提供可供医生评估的信息，以帮助有效诊断某些肺部疾病并为患者决定正确的治疗方法。此外，PFT 是非侵入性手术，通常由医生推荐给无需住院的患者。肺活量测定法是一种商业肺功能测试系统。肺活量测定测试可用于确定患者是否患有肺部疾病、肺部疾病的类型、肺部疾病的进展以及肺部疾病的损害。肺量计测量气流，可以评估患者的各种肺部疾病。因此，肺部相关疾病发病率的上升推动了北美肺功能测试系统的使用。
北美肺功能测试系统市场概述
北美肺功能测试系统市场概述
北美肺功能测试系统市场分为美国、加拿大和墨西哥。 2022年，美国在北美肺功能测试系统市场中占据最大份额。北美肺功能测试系统市场的增长归因于便携式系统的大量实施以及医生群体中呼吸设备使用量的增加（诊所）。
北美肺功能测试系统市场收入及 2028 年预测（百万美元）
北美肺功能测试系统市场细分
北美肺功能测试系统市场根据类型、测试类型、组件、应用、最终用户和国家/地区进行细分。
根据类型，北美肺功能测试系统市场分为基于推车的 PFT 系统和固定式 PFT 系统。 2022 年，基于推车的 PFT 系统细分市场在北美肺功能测试系统市场中占据较大份额。
根据测试类型，北美肺功能测试系统市场分为肺活量测定、肺容量、气体交换测试、最大通气量、氧滴定测试等。 2022 年，肺活量测定领域在北美肺功能测试系统市场中占据最大份额。
根据组件，北美肺功能测试系统市场分为硬件、软件和服务。 2022年，硬件细分市场在北美肺功能测试系统市场中占据最大份额。
根据应用，北美肺功能测试系统市场分为慢性阻塞性肺疾病和慢性阻塞性肺疾病。肺部疾病、哮喘、慢性呼吸短促、限制性肺病等。 2022 年，慢性阻塞性肺疾病细分市场在北美肺功能测试系统市场中占据最大份额。
根据最终用户，北美肺功能测试系统市场分为医院、专科诊所和诊断实验室。 2022 年，医院细分市场在北美肺功能测试系统市场中占据最大份额。
根据国家/地区，北美肺功能测试系统市场细分为美国、加拿大和墨西哥。 2022 年，美国在北美肺功能测试系统市场中占据主导地位。
COSMED Srl、KoKo PFT Ltd、MGC Diagnostics Corp、Morgan Scientific Inc、ndd Medical Technologies Inc、PulmOne Advanced Medical Devices Ltd、Schiller AG 和 Vyaire Medical Inc 是北美肺功能测试系统市场的领先公司。
Strategic insights for North America Pulmonary Function Testing Systems involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 108.42 Million |
| Market Size by 2028 | US$ 160.73 Million |
| Global CAGR (2022 - 2028) | 6.8% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Pulmonary Function Testing Systems refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Pulmonary Function Testing Systems Market is valued at US$ 108.42 Million in 2022, it is projected to reach US$ 160.73 Million by 2028.
As per our report North America Pulmonary Function Testing Systems Market, the market size is valued at US$ 108.42 Million in 2022, projecting it to reach US$ 160.73 Million by 2028. This translates to a CAGR of approximately 6.8% during the forecast period.
The North America Pulmonary Function Testing Systems Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Pulmonary Function Testing Systems Market report:
The North America Pulmonary Function Testing Systems Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Pulmonary Function Testing Systems Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Pulmonary Function Testing Systems Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Pulmonary Function Testing Systems Market
